If you have been reading about research compound and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.
SR9009 is generally described as poorly soluble in water and more soluble in organic solvents such as dimethyl sulfoxide and ethanol. Stock solutions are commonly prepared in an organic solvent before dilution into an aqueous buffer or vehicle. Precipitation can occur if the organic fraction is reduced too quickly or if the final concentration exceeds the compound's solubility limit. Sonication or gentle warming may aid dissolution in some protocols, but excessive heat can promote degradation. Container material and pH can also influence observed solubility.
For long-term storage, SR9009 is typically kept as a solid at low temperature, protected from moisture and light. Desiccated conditions limit hydrolysis, while opaque containers reduce photochemical breakdown. Solutions are less stable than solids and are often stored frozen in aliquots to avoid repeated freeze-thaw cycles. Stability data are not standardized across all suppliers, so users should rely on certificate-of-analysis information when available. Degradation may appear as color change, precipitate, or decreased chromatographic purity.
Laboratory identification of SR9009 typically relies on chromatographic separation coupled to mass spectrometry, often with ultraviolet detection as a secondary check. Nuclear magnetic resonance spectroscopy can confirm molecular structure when a reference standard is available. Because many suppliers sell the compound as a research chemical, independent identity testing is important for experimental reproducibility. A single retention time is not sufficient proof of identity, especially when related compounds may be present. Purity assessments usually report a percentage based on area normalization.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Visual inspection is not sufficient for identity. |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water; stock solutions use organic solvent. |
| Storage | -20°C, desiccated, protected from light | Limits hydrolysis and photodegradation. |
| Analytical method | HPLC-UV/MS | Used for identity and purity assessment. |
| Synonyms | SR9009, Stenabolic | Naming varies by supplier. |
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
Laboratory studies often administer SR9009 by injection because oral absorption appears poor in rodents. Reported pharmacokinetic properties include rapid metabolism and low systemic exposure after oral dosing. Human pharmacokinetic data are sparse, so absorption, distribution, metabolism, and excretion in people are not well defined. Some research explores related REV-ERB compounds with improved drug-like properties. Regulatory approval for any REV-ERB agonist as a human medicine has not been granted to date.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ, also called NR1D1 and NR1D2. These receptors help regulate circadian rhythms and metabolic gene programs. The compound was developed for laboratory research, not as an approved therapeutic. Its identity is distinct from steroid hormones and selective androgen receptor modulators. Scientific interest centers on how REV-ERB activation changes gene expression in cells and animal models.
At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.
=== Reports === "Combattre les violences faites aux femmes" [Combating violence against women] (in French). Archived from the original on April 23, 2021. "Bilan de l'application des dispositifs promouvant l'égalité professionnelle entre femmes et hommes" [Review of the implementation of measures promoting professional equality between women and men] (in French). Archived from the original on April 23, 2021. "Femmes éloignées du marché du travail" [Women who are distant from the labor market] (in French). Archived from the original on January 28, 2021. "Kit pour agir contre le sexisme" [Kit to take action against sexism] (in French). November 14, 2016. Retrieved May 8, 2025. "Le sexisme dans le monde du travail" [Sexism in the workplace] (PDF). Conseil Supérieur de l'égalité professionnelle (in French). Archived from the original (PDF) on March 31, 2015. "Écart de rémunération entre hommes et femmes en Europe : faits et chiffres" [Gender pay gap in Europe: facts and figures]. Parlement Européen (in French). March 4, 2020. Archived from the original on January 23, 2021.
=== Environment === Deforestation in the Brazilian Amazon rainforest fell 61% in January 2023 from a year earlier following a series of anti-logging and anti-mining operations launched by government agencies under Lula, according to satellite data. In June 2023, the Environment Ministry announced a plan to curb deforestation in Brazil's Legal Amazon, and immediately embargoed all activities being developed inside conservation parks in the region. Additionally, the government announced the creation of 3 million hectares (7,413,161.44 acres) in protected areas until 2027/ the creation of tracking system using geopositioning for Amazon agricultural products and ecolabels were announced as well. In July 2023, deforestation in the Brazilian Amazon was reported to have fallen 34% over the previous six months while deforestation in the Brazilian Atlantic forest dropped 42% from January to May 2023 comparatively to the same period of time in 2022. In November 2023, Brazil's National Institute for Space Research (INPE) reported that the Amazon deforestation rate fell 22% between August 2022 and July 2023, compared to its previous 2021–2022 report (during Jair Bolsonaro's presidency). Considering only the period of the Lula government, the drop is accentuated to 49.7% compared to the same period of the previous year. Deforestation in protected areas fell the most, being the lowest in 9 years. In total, Imazon highlighted that 2023 had the lowest deforestation rate since 2017.
==== Cave 60: "Largest Cave" ==== Cave 60, also called the "Largest Cave", is a cave which was expanded over several periods, and still contained a few paintings belonging to the refined style of the Classical First Period, while most of the paintings are from the later Second Period. The cave is known for its portrait of royal donors, characteristically accompanied by a label in Brahmi script. This is the only known possible instance of a portrait of royal donors in a painting of the First Style, whereas they occur very often during the second period. The style of painting is very similar to that seen in the Cave of the Painters (Cave 207). The hairstyle of the male donor is quite similar to that of the famous painter in the Cave of the Painters. The cave is also remarkable for the presence of Sasanian-style ducks in a bead roundel frames, a well-known motif which spread through Central Asia, and is known from the dress of a Central Asian ambassador from Afrasiab. This motif was likely painted later than the portraits of the royal donors.
Sources: en.wikipedia.org
According to Human Rights Watch, as of 2009 Syria's poor human rights situation had "deteriorated further". Authorities arrested political and human rights activists, censored websites, detained bloggers, and imposed travel bans. Syria's multiple security agencies continue to detain people without arrest warrants. No political parties were licensed and emergency rule, imposed in 1963, remained in effect. Various torture techniques deployed in Syrian detention centres and prisons include routine beatings, rapes, sexual violence, "Bisat al-rih" (flying carpet), etc. Before the outbreak of Syrian revolution in 2011, Ba'athist Syria's human rights situation was regarded as among the worst in the world. Ba'athist military apparatus arbitrarily arrested numerous civilians, tortured dissidents and violently persecuted Syrian Kurds. The Syrian police continued to arrest journalists, target human rights activists, censor websites, ban media outlets, detain bloggers, and impose travel bans. Arbitrary detentions, torture, and forced disappearances were widespread. Kurdish dissidents and political activists were regularly arrested and imprisoned. Expressions of Kurdish identity were banned, with Kurds being systematically discriminated and treated as "second-class citizens" in Ba'athist Syria. The scale of the brutal violence and state terrorism unleashed by the Assad regime and his foreign backers across the country after the eruption of the 2011 Syrian revolution was unprecedented, far outstripping the actions of other Arab autocrats who repressed the Arab Spring.
The NO can then contribute to two suggested pathways. Under typical conditions, nitric oxide (NO) interacts non-covalently with the heme and copper (Cu) subunits of CCO, competing with oxygen molecules and inhibiting cellular respiration, leading to reduced production of adenosine triphosphate (ATP). Low energy light can revise the mitochondrial inhibition of cellular respiration by photodissociating of NO from CCO, and thereby increasing ATP synthesis. The second pathway proposes that released nitric oxide (NO) will boost Cytochrome c Oxidase (CCO) activity, as an enzyme nitrite reductase. This mechanism includes the transfer of electrons to oxygen molecules, resulting in the production of water and reactive oxygen species (ROS). The ROS then activates enzymes necessary for producing vital cellular components like nucleic acids and proteins. LED therapy may also increase ROS, which may activate transcription factors that manage genes important for cell growth, cytokine production, and making growth factors for cell repair and proliferation.
Regional treatment centres had also been set up, with large increases in the number of infected in the South Pyongan and South Hamgyong provinces. On 20 May, 168 confirmed cases of COVID-19 were reported, with cases of reported fever nearing 2 million, according to NK News. On 3 June, NK News reported that GAVI had received information that North Korea had started its vaccination rollout with Chinese vaccines, with an anonymous source telling Radio Free Asia that the first doses were being administered to soldiers working in the construction sector. From around June, vehicles had started reappearing in satellite imagery in Pyongyang, which suggested that the lockdown was at least being partially lifted in Pyongyang, with a source alleging that restrictions were relaxed to allow for a few hours of outdoor time every day from late May, though provincial cities appeared to be still locked down.
After a short career break, he returned to work in 1978, appearing in two stage productions: 1978's The Mighty Gents, winning a Drama Desk Award and a Clarence Derwent Award for his role as a wino, and White Pelicans. Freeman continued to work in theater and a year later, appeared in the Shakespearean tragedies Coriolanus, receiving the Obie Award in 1980 for the title role as well as Julius Caesar. In 1980, he had a small role as Walter in the drama Brubaker, which starred Robert Redford as a prison warden. Freeman next appeared in the television film, Attica (1980), which is about the 1971 Attica Prison riot and its aftermath. A year later he had a lead role in Peter Yates' Eyewitness with co-stars William Hurt and Sigourney Weaver. From 1982 to 1984, Freeman was a cast member of the soap opera Another World, playing architect Roy Bingham. After several small roles in dramas, he starred in Marie (1985), a film adaptation of Marie: A True Story by Peter Maas; he portrayed Charles Traughber. He also appeared in the miniseries The Atlanta Child Murders. Freeman also had a small role in the drama That Was Then... This Is Now, based on the novel of the same name by S. E. Hinton. In the mid-1980s, he began accepting prominent supporting roles in feature films, earning him a reputation for depicting wise, fatherly characters. In addition to television films, in 1987, Freeman played a violent street hustler, a role that diverged from his previous roles, in Street Smart co-starring Christopher Reeve and Kathy Baker.
Sources: en.wikipedia.org
In mass spectrometry, the molecular mass of a small molecule is usually reported as the monoisotopic mass: that is, the mass of the molecule containing only the most common isotope of each element. This also differs subtly from the molecular mass in that the choice of isotopes is defined and thus is a single specific molecular mass out of the (perhaps many) possibilities. The masses used to compute the monoisotopic molecular mass are found in a table of isotopic masses and are not found in a typical periodic table. The average molecular mass is often used for larger molecules, since molecules with many atoms are often unlikely to be composed exclusively of the most abundant isotope of each element. A theoretical average molecular mass can be calculated using the standard atomic weights found in a typical periodic table. The average molecular mass of a very small sample, however, might differ substantially from this since a single sample average is not the same as the average of many geographically distributed samples.
== Domestic types == Domestic refrigerators and freezers for food storage are made in a range of sizes. Among the smallest is a 4-litre (0.14 cu ft) Peltier refrigerator advertised as being able to hold 6 cans of beer. A large domestic refrigerator stands as tall as a person and may be about 1 metre (3.3 ft) wide with a capacity of 600 litres (21 cu ft). Some models for small households fit under kitchen work surfaces, usually about 86 centimetres (34 in) high. Refrigerators may be combined with freezers, either stacked with refrigerator or freezer above, below, or side by side. A refrigerator without a frozen food storage compartment may have a small section just to make ice cubes. Freezers may have drawers to store food in, or they may have no divisions (chest freezers). Refrigerators and freezers may be free-standing, or built into a kitchen's cabinet. Three distinct classes of refrigerator are common:
It was initially sold in a flask-like container shaped with a narrow neck to prevent moisture from seeping into the product. Another theory is that in 1916, Tanaka Foods developed "Travel Friend"(旅行の友) in cans at the request of the military as a nutritional supplement. This is a blend of dried small fish powder seasoned with soy sauce, sesame, seaweed, and egg. In 1927, a grocery retailer in Fukushima City named Seiichirō Kai developed a mixture consisting of ishimochi (石持 or 石首魚, silver white croaker, Pennahia argentata) with soy sauce seasoning, kelp, and sesame seeds. He founded the Marumiya Food Research Institute. Kai called his product Kore Wa Umai (これは旨い, 'This Is Tasty'); it was popular on its release. Although Kore Wa Umai was initially considered a luxury item for the affluent who were able to consume white rice on a regular basis, it later was made accessible to the Japanese working class.
Sources: en.wikipedia.org
Liquid chromatography with mass spectrometry is a common approach. Ultraviolet detection and nuclear magnetic resonance can support identification when suitable standards are available.
The solid is generally kept cold, dry, and protected from light. Solutions are often frozen in single-use aliquots to reduce repeated freeze-thaw cycles.
It indicates a material sold for laboratory study, not for human use. The label does not guarantee pharmaceutical purity, sterility, or regulatory approval.
Its legal status depends on the country and intended use. It is not an approved medicine in major jurisdictions. In sport, it is prohibited by anti-doping rules.